Concentric by Ginkgo, the biosecurity and public health unit of Ginkgo Bioworks (DNA), announced that it has entered into a Co-Marketing Agreement with Illumina (ILMN) to partner on expanding biosecurity capabilities globally. Under the agreement, the partners aim to demonstrate the use of Illumina products with Concentric’s bioradar, to accelerate the expansion of the pathogen monitoring network in a way that empowers countries, as well as increase the scale and scope of pathogen genomic surveillance globally. Concentric and Illumina will work together to market their solutions, with the aim to enhance early warning of emerging and novel pathogens and fill gaps in global biosurveillance infrastructure. The shared goal is to help build local capacity for biosurveillance to empower countries rather than having to outsource biosecurity to unreliable third parties.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ILMN:
- Illumina sees less instrument placements in 2024 vs. 2023
- llumina sees FY24 results ‘very similar’ to FY23
- Illumina (NASDAQ:ILMN) Shines on Impressive Q4 Preliminary Numbers
- Early notable gainers among liquid option names on January 9th
- Illumina Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2023